Business
Ventana Biotech Inc Starts New Round of Funding
(via Thenewswire.ca)
About this update from Vanta Holdings Inc.
[{"type":"text","content":"Ventana Biotech Inc Starts New Round of Funding\n\n(via Thenewswire.ca)\nJanuary 7, 2009 - Ventana Biotech Inc (\"Ventana\") (VNTA.PK), a biotechnology company that is developing a ground breaking appetite-suppressing chewing gum, today announced it is starting the next round of fund raising.\n\nVentana will be starting it's next round of fund raising in January 2009 to support the R&D efforts of its highly anticipated and innovative anti-obesity chewing gum treatment. Ventana will engage in a USD5m round of funding which will see the company through to 2010 and enable the company to finalize its R&D process as well as build up the management team and collaboration partners. Ventana is planning to start business development with Big Pharmaceutical companies for possible license and royalty agreements. It is Ventana's aim to solely seek license and royalty agreements with Big Pharma's as it provides the most cost efficient return-of-investment for shareholders rather than going through the costly process of doing in-house clinical trials.\n\nAbout Ventana Biotech Inc\n\nVentana is positioning itself as the leading bioscience company in the development and commercial licensure of novel therapeutic anti-obesity drug treatment. The company leverages cutting-edge research collaborations to achieve breakthroughs in innovative anti-obesity treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies.\n\nFORWARD-LOOKING STATEMENTS:\n\nStatements about Ventana's future expectations and all other statements in this press release other than historical facts are \"forward-looking statements\" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. Ventana's actual results could differ materially from expected results. Ventana does not undertake any obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this objective; Ventana will appropriately inform the public.\n\nFor more information about Ventana Biotech Inc please contact [email protected]\nCopyright (c) 2009 Thenewswire.ca - All rights reserved.\n","length":24...